ARCHIVES

FDA Expands Nexavar Indication To Include Thyroid Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Circulating Tumor Cells Predict Treatment Resistance In Study Of Metastatic Breast Cancer

August 30, 2013

Lasagna Committee Report Advocates Faster Drug approval, Insurance Coverage For Investigational Drugs, Ancillary Costs

September 7, 1990

Duke Tells ACS The Check for $437,400 Is In The Mail

December 10, 2010

Selumetinib Displays Positive Results, 60% with Stable Disease

April 29, 2011

Rituximab Maintenance Improves Survival In Relapse

February 27, 2009

Tivozanib Does Not Improve OS Compared to Sorafenib

February 22, 2013